Showing results (521-530 of 105,986) with videos related to

Sort By:
Pageof 10,599
Journal of Chemical Ecology|November 23, 2013
Allelochemical regulation of reproduction and seed germination of two BrazilianBaccharis species by phytotoxic trichothecenesJ O Kuti, B B Jarvis, N Mokhtari-Rejali, et al.
BMC Pregnancy and Childbirth|July 25, 2022
'Beyond the Bump': an online wellbeing and lifestyle pilot program during COVID-19 for first year postpartum mothers: a research articleHannah E Christie, Lauren A Roach, Meredith Kennedy, et al.
The Journal of Antimicrobial Chemotherapy|December 3, 2004
The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in EuropeRobert G Masterton, Joseph L Kuti, Philip J Turner, et al.
The Central African Journal of Medicine|September 1, 1994
Typhoid fever associated with severe hepatitisJ O Olubodun, J A Kuti, B O Adefuye, et al.
Clinical Therapeutics|October 13, 2004
Optimizing antimicrobial pharmacodynamics: dosage strategies for meropenemHolly M Mattoes, Joseph L Kuti, George L Drusano, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 3, 2007
Addressing resistance evolution in Pseudomonas aeruginosa using pharmacodynamic modelling: application to meropenem dosage and combination therapyL Santos Filho, K J Eagye, J L Kuti, et al.
Pediatric Blood & Cancer|May 8, 2009
Optimizing bactericidal exposure for beta-lactams using prolonged and continuous infusions in the pediatric populationJoshua D Courter, Joseph L Kuti, Jennifer E Girotto, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2011
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administrationSeth T Housman, Pamela R Tessier, David P Nicolau, et al.
Scandinavian Journal of Infectious Diseases|September 30, 2014
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing EnterobacteriaceaeLisa M Blanchette, Joseph L Kuti, David P Nicolau, et al.
International Journal of Antimicrobial Agents|May 16, 2022
Pharmacokinetics and Time above the MIC Exposure of Cefepime in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (ECMO)Abigail K Kois, Jason A Gluck, David P Nicolau, et al.
Pageof 10,599